Posted on 09/02/06
Pfizer to unveil elixir for future
Pfizer Inc. goes under the microscope tomorrow, giving analysts and investors a detailed view of how the drug giant aims to rev up its stalled money machine in the face of continuing restructuring and generic competition.
The full text of this article has 548 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
